Brief: Aprea Therapeutics Posts Q3 Loss Per Share Of $0.45

Aprea Therapeutics

08/11/2021 22:50

Nov 8 (Reuters) - Aprea Therapeutics Inc  APRE.O :
    * APREA THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES UPDATE ON BUSINESS OPERATIONS
    * Q3 LOSS PER SHARE $0.45
    * EXPECTS CASH BURN FOR FULL YEAR 2021 TO BE BETWEEN $30.0
MILLION
AND $35.0 MILLION
    * APREA THERAPEUTICS - BELIEVES CASH AND CASH EQUIVALENTS AS
OF
SEPT 30,2021 TO BE SUFFICIENT TO MEET CURRENT PROJECTED
OPERATING REQUIREMENTS INTO 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4J0jcT 
Further company coverage:  APRE.O 

 ((Reuters.Briefs@thomsonreuters.com;))